New Jersey-based nutritional supplements supplier The Vitamin Shoppe announced its launching of Whole Health Rx, a telehealth service that will connect users with providers to help them access GLP-1 medications for weight management.
GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, but have recently become more popular for managing...
MediSecure, a provider of a digital prescription platform, is the latest in Australia to fall victim to a major ransomware attack by unidentified actors.
On Thursday, 16 May, the company reported a cyber attack "impacting the personal and health information of individuals" in its system. The company's website and phone lines have since gone offline.
"While we continue to gather more information...
Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it had secured $15 million in Series E investment.
Existing investors Canaan Partners and New Leaf Venture Partners led the round.
WHAT IT DOES
The company provides technology to help employers secure lower drug pricing plans. Its software also allows sponsors to garner...
Finland-based Oura, the maker of its namesake health tracking ring, announced it added two heart health monitoring features to its Oura Ring wearable device, Cardiovascular Age (CVA) and Cardio Capacity, which will be available later this month on Oura Ring Gen3 devices for both Android and iOS.
The CVA feature uses data from the device to estimate a user's cardiovascular age relative to their...
Oncology-focused digital health company Flatiron Health, which Roche acquired in a $1.9 billion deal in 2018, is announcing a strategic collaboration with the Association of Cancer Care Centers (ACCC) to promote access to clinical trials in the community setting, improve clinical study efficiency and enhance the gathering of study-related data.
ACCC is an advocacy group comprising a nationwide...
A study performed by Google Research, in collaboration with Google DeepMind, reveals the tech giant expanded the capabilities of its AI models for Med-Gemini-2D, Med-Gemini-3D and Med-Gemini Polygenic.
Google said it fine-tuned Med-Gemini capabilities using histopathology, dermatology, 2D and 3D radiology, genomic and ophthalmology data.
The company's Med-Gemini-2 was trained on conventional...
The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, thus enabling researchers to use it to detect arrhythmias or abnormal heart beat.
Apple's tool is the first digital health tool to be qualified under the MDDT program, a voluntary program aimed at evaluating devices for use in...
AI-enabled protein design company Profluent has leveraged artificial intelligence to design an open-source gene editor called OpenCRISPR-1, demonstrating the technology can be used to create molecules with the power to edit human DNA.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology, developed more than a decade ago, allows scientists to modify DNA sequences within...
OpenAI and Moderna announced the pair have expanded their partnership to offer the pharma giant's employees access to ChatGPT Enterprise, a platform that allows customizable GPTs to be developed for a specific purpose.
Through ChatGPT Enterprise, users can create GPTs by beginning a conversation with ChatGPT, then providing extra knowledge on a subject or giving it instructions. Users can also...
Xaira Therapeutics, an AI-enabled drug discovery and development company, announced its launch with more than $1 billion in capital.
The biotechnology company is a joint incubation by ARCH Venture Partners and Foresite Labs, the lead investors in the funding round.
Lux Capital, Two Sigma Ventures, F-Prime, Rsquared, SV Angel, Menlo Ventures, Sequoia Capital, NEA, the Parker Institute for...
